Upcoming changes to the National Immunisation Program in 2023

In 2023 there will be changes to the National Immunisation Program including a new listing of Vaxelis® vaccine as an alternative DTPa-hepB-IPV-Hib vaccine for children at 2, 4 and 6 months of age (effective from 1 July 2023) and Shingrix® vaccine for prevention of herpes zoster (shingles) and post-herpetic neuralgia to replace Zostavax® (pending regulatory approvals) (effective from 1 November 2023).

The Australian Government will publish an updated NIP Schedule and a news item containing this advice on the Department of Health’s website on 1 July 2023. Providers can also get the latest NIP updates by subscribing to the email list.